Advertisement
What we know and what we are still learning
The road to FDA approval and what's ahead
Dr. Mazzone shares his vision as the new editor-in-chief of CHEST
Multidisciplinary advice on the care of complex patients with nuanced needs
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Rule out other factors first
Acclaimed clinician, researcher and educator
Largest trial to date is studying use of nintedanib
Multicenter trial studies use of bardoxolone
Multicenter trial studies use of pirfenidone
PH due to miscellaneous causes
Advertisement
Advertisement